Sonnet BioTherapeutics Holdings, Inc. filed a Form 8-K on January 21, 2025, with the Securities and Exchange Commission announcing the expansion of its Phase 1 SB101 trial. The company’s trial aims to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback